VitalConnect, a leader in biosensor technology, specializing in ambulatory cardiac monitoring, announced the closing of $100 million in financing through a combination of equity and debt capital.

The equity financing was led by new investor Ally Bridge Group, with significant participation from the Company's existing investors, including EW Healthcare Partners, MVM and Revelation Partners while Trinity Capital provided the debt financing. In conjunction with the financing, VitalConnect strengthens its Board of Directors with the addition of Steven Plachtyna from Ally Bridge Group and Eric Shiozaki from Revelation Partners.